BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16792828)

  • 21. Is a policy of cervical screening for all women attending a genito-urinary medicine clinic justified?
    Stedman Y; Woodman CB; Donnelly BJ
    J Public Health Med; 1995 Mar; 17(1):90-2. PubMed ID: 7786575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
    Thoresen SO; Skare GB; Sandvin O
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
    Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audit of cervical screening in women with HIV infection in the Auckland and Northland regions of New Zealand.
    Grewal J; Lowe M; Gerrard H; Henley R; Perkins N; Briggs S
    N Z Med J; 2010 Jul; 123(1319):71-8. PubMed ID: 20717179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new method for the classification of invasive cervical cancer screening histories.
    Bagnall H; Pearmain P; Clare J; Lawrence G
    J Med Screen; 2006; 13(3):137-47. PubMed ID: 17007655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Consequences of incorrect interpretation of vaginal smear tests in a screening program].
    Lynge E; Arffmann E; Poll P; Andersen PK
    Ugeskr Laeger; 1994 Apr; 156(17):2594-6. PubMed ID: 8016968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in abnormal cancer screening results in the United States of America.
    Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
    J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pap smear screening and invasive cervical cancer.
    Brown RK; Barker WH
    J Fam Pract; 1982 Nov; 15(5):875-9. PubMed ID: 7130915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity of women's self-reports of cancer screening test utilization in a managed care population.
    Caplan LS; McQueen DV; Qualters JR; Leff M; Garrett C; Calonge N
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1182-7. PubMed ID: 14652278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon].
    Mignotte H; Perol D; Fontanière B; Nachury LP; Blanc-Jouvand A; Fouillat V; Chauvin F; Lasset C
    Bull Cancer; 1999 Jun; 86(6):573-9. PubMed ID: 10417430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The uptake of cervical cancer screening by renal transplant recipients.
    Courtney AE; Leonard N; O'Neill CJ; McNamee PT; Maxwell AP
    Nephrol Dial Transplant; 2009 Feb; 24(2):647-52. PubMed ID: 18952575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pap smear histories in a medical clinic: accuracy of patients' self-reports.
    Fruchter RG; Rones K; Roth T; Webber CA; Camilien L; Boyce JG
    N Y State J Med; 1992 Oct; 92(10):421-4. PubMed ID: 1436809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening].
    Berkers LM; van Ballegooijen M; van Kemenade FJ; Rebolj M; Essink-Bot ML; Helmerhorst TJ; Habbema JD
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1288-94. PubMed ID: 17624160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quasi-randomized trial on the effectiveness of an invitation letter to improve participation in a setting of opportunistic screening for cervical cancer.
    de Jonge E; Cloes E; Op de Beeck L; Adriaens B; Lousbergh D; Orye GG; Buntinx F
    Eur J Cancer Prev; 2008 Jun; 17(3):238-42. PubMed ID: 18414195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for cervical cancer among female physicians and their relatives in Taiwan: a population-based comparative study.
    Chen LS; Huang N; Tsay JH; Wang PJ; Chou YJ; Chou P; Lee CH
    Prev Med; 2007 Jun; 44(6):531-5. PubMed ID: 17467786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balancing uncertainty and acceptance: understanding Chinese women's responses to an abnormal cervical smear result.
    Twinn S
    J Clin Nurs; 2006 Sep; 15(9):1140-8. PubMed ID: 16911055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening.
    Wikström I; Stenvall H; Wilander E
    Acta Obstet Gynecol Scand; 2007; 86(6):720-5. PubMed ID: 17520406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Follow-up of non-negative cervical cytological smears in the county of Funen].
    Dahl MB; Hølund B; Sørensen B; Ahrons S; Grinsted P; Poulsen EF
    Ugeskr Laeger; 1998 Sep; 160(40):5798-801. PubMed ID: 9782760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical cancer screening: A Slovenian experience.
    Primic-Zakelj M; Repse-Fokter A
    Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.